Documente Academic
Documente Profesional
Documente Cultură
ARTIFICIAL BLOOD 2
The hemoglobin molecule consists of two alpha Modified hemoglobin solutions must undergo
subunits and two betas. Which have an affinity bioengineering processes to overcome the
for O2, so when an O2 molecule binds to one of drawbacks of free hemoglobin:
the subunits, it increases the affinity of the other
a) Conjugation of the dimers and
subunits for the gas, and when one breaks off,
polymerization of the hemoglobin
it facilitates that the O2 is detached from the
molecules, thereby increasing their half-
other subunits. This circulates encapsulated
life in the plasma.
inside the erythrocytes so it is inferred that it has
b) Modification of the affinity for O2 by the
a half-life of 120 days, 60-90 in transfusional
covalent addition of paradoxal
blood. Although this blood is not the true one, to
phosphate, which provides an affinity
call it in a way, it will respect what are the two
curve for O2 similar to that of
indicators that tell us what our blood is like, the
intraerythrocytic hemoglobin.
different blood types (A, B, AB, O) and the Rh
c) Surface modification with dextran or
factor. There are two major families:
other biological polymers that hide the
perfluorocarbons and modified hemoglobin
hemoglobin molecule to the
solutions.
reticuloendothelial system and thus
Perfluorocarbons are the first synthetic increase its half-life.
compounds that were tested as O2
As for its origin, hemoglobin can be obtained
transporters. The presence of fluorine atoms
from expired human blood, from bovine blood
makes the perfluorocarbon molecule very
or by genetic recombination. Bovine
spongy and the gases dissolve in it more easily
hemoglobin already has an affinity curve for O2
than in water. Thus, O2 is transported dissolved
similar to intraerythrocytic hemoglobin.
in the perfluorocarbon, and not because it has a
particular affinity for these compounds. They “It's a dry powder that looks like paprika,
are small molecules, which diffuse well into the basically," said Doctor. "It can be stored in a
tissues and end up being eliminated through plastic IV bag that a doctor could carry, in the
respiration. ambulance or in a backpack, for a year or
more." When they need to use it, they pour
sterile water into the bag, mix it, and are ready
to inject it. Right now".Dr. Allan Doctor, critical
care specialist at the University Of Washington
School Of Medicine, St. Louis.
ARTIFICIAL BLOOD 3
ADVANTAGE DISADVANTAGES
The advantages of perfluorocarbons are that The side effects of hemoglobin solutions (Hb)
they are inert, easily storable, cheap and radio are: Vessel activity, nephrotoxicity, interference
opaque compounds. They are insoluble in with the mononuclear phagocytic system,
water, so they have to be administered in the oxidation during storage, antigenicity, poor
form of emulsion, and at high doses they oxygen hauling, Histamine release and iron
produce fever and thrombocytopenia, their deposits. Because of this, it is not possible to
capacity to transport O2 is a linear function of administer hemoglobin in its native form, hence
the pO2, so the patient must be breathing O2 to it is necessary to modify it. The origin of the
95 %. The new red blood cells are designed to artificial cells is related to the oxygen carriers in
emulate the vital functions of the natural ones, the form of poly hemoglobins and conjugated
so if their safe use for humans is confirmed, they hemoglobins.
could represent an alternative to transfusions,
especially valuable in areas and situations
where blood is difficult to obtain or store.
ARTIFICIAL BLOOD 4
TRANSFUSIONS
Now, however, we already know something more about this synthetic blood. And it's a great
medical breakthrough, because, despite all the medical advances in recent years, many people
die bleeding after some kind of trauma while waiting for a transfusion.
A blood transfusion is the transfer of blood or blood components from one subject to another. A
blood transfusion can save the patient's life, hence the need for health services to seek to
maintain an adequate supply of safe blood and to ensure that it is used accordingly.
Transfusions may be of various types depending on the need for the recipient to suffer from the
disease. The most common donation is the red blood cell concentrate. The diseases that can
make essential the transfusion of erythrocytes concentrates are numerous: severe hemorrhage,
acute leukemia, anemia after treatments of chemotherapy and radiotherapy against the cancer,
medullary aplasia, major surgery, anemia Hemolytic, etc., but all of them have as a common key
the existence of a severe anemia that is not possible to be corrected by other means and which
seriously compromises the cardiovascular and oxygen function of the blood in the organism.
The ErythroMer and POLYHB projects represent a major medical breakthrough. One of the
project's leaders, Dr. Pan, has confirmed that this synthetic blood is capable of transporting
oxygen from one side to another, one of the most complex processes of replicating when artificial
blood is investigated.
ARTIFICIAL BLOOD 5
LIMITATIONS-DISADVANTAGES
The risks associated with blood transfusion have been the main argument that has been
managed to reduce the use of blood and to encourage the application of possible substitutes for
the homologous transfusion, as well as the risk of transmission of diseases Mainly the risks of
transmission of HIV and hepatitis B and C viruses, and the difficulty presented by those who
need an urgent transfusion and yet by the blood type reduces the possibility of getting a donor,
form points in favor of the search for alternatives to the current transfusion.
CONCLUSION
At the present time of unknown much about the artificial blood as well as the efficacy of its use,
but it is a subject of utmost importance since with constant research and contributions of the
science, this perhaps is a great contribution to the humanity in the not very distant future.
ARTIFICIAL BLOOD 6
BIBLIOGRAPHY
Blair, L. . (2015). La sangre artificial podría terminar con la dependencia de los donantes de sangre. Enero 20, 2017,
de El blog de la salud Sitio web:11. https://www.elblogdelasalud.info/la-sangre-artificial-podria-terminar-con-la-
dependencia-de-los-donantes-de-sangre/14944
EFE, A., Galicia, L., g., a., RAMALLAL, X., Vázquez, O., & LOSADA, P. (2017). Crean la primera sangre artificial para
salvar a víctimas de catástrofes. La Voz de Galicia. Retrieved 23 March 2017, from
http://www.lavozdegalicia.es/noticia/salud/2016/12/05/crean-primera- sangre-artificial-salvar-victimas-
catastrofes/0003_201612G5P23992.htm
Debate, E. (2017). ¿Has escuchado sobre la sangre artificial?. EL DEBATE. Retrieved 23 March 2017, from
https://www.debate.com.mx/salud/Has- escuchado-sobre-la-sangre-artificial-20161206-0055.html
BBC Mundo | Ciencia | Sangre artificial: prueba definitiva. (2017). News.bbc.co.uk. Retrieved 23 March 2017, from
http://news.bbc.co.uk/hi/spanish/science/newsid_3207000/3207881.stm
Jean-François Pillou.CCM Salud Sangre Artificial Definicion (2013) 6 de dic, from https://salud.ccm.net/faq/8294-
sangre-artificial-definicion
ARTIFICIAL BLOOD 7